Establishment of a humanized patient-derived xenograft mouse model of high-grade serous ovarian cancer for preclinical evaluation of combination immunotherapy.

Tandaric L, Bjørge L, Lode MR, Torkildsen CF, Aehnlich P, Elnour R, Costea DE, Akslen LA, Thomsen LCV, McCormack E, Kleinmanns K

Open source

DOI
10.1002/1878-0261.70231
Published
2026 Sep
Container
Molecular oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/1878-0261.70231,
  title = {Establishment of a humanized patient-derived xenograft mouse model of high-grade serous ovarian cancer for preclinical evaluation of combination immunotherapy.},
  author = {Tandaric L and Bjørge L and Lode MR and Torkildsen CF and Aehnlich P and Elnour R and Costea DE and Akslen LA and Thomsen LCV and McCormack E and Kleinmanns K},
  year = {2026},
  journal = {Molecular oncology},
  doi = {10.1002/1878-0261.70231},
  url = {https://doi.org/10.1002/1878-0261.70231}
}

RIS

TY  - JOUR
TI  - Establishment of a humanized patient-derived xenograft mouse model of high-grade serous ovarian cancer for preclinical evaluation of combination immunotherapy.
AU  - Tandaric L
AU  - Bjørge L
AU  - Lode MR
AU  - Torkildsen CF
AU  - Aehnlich P
AU  - Elnour R
AU  - Costea DE
AU  - Akslen LA
AU  - Thomsen LCV
AU  - McCormack E
AU  - Kleinmanns K
PY  - 2026
JO  - Molecular oncology
DO  - 10.1002/1878-0261.70231
UR  - https://doi.org/10.1002/1878-0261.70231
ER  - 

APA

L, T., L, B., MR, L., CF, T., P, A., R, E., DE, C., LA, A., LCV, T., E, M., & K, K. (2026). Establishment of a humanized patient-derived xenograft mouse model of high-grade serous ovarian cancer for preclinical evaluation of combination immunotherapy.. Molecular oncology. https://doi.org/10.1002/1878-0261.70231

Source records